For instance, a recent study has shown that toxicity in ALS does not develop through a single aggregate structure or aggregation process, given the significant differences between FUS and TDP-43 aggregation processes and subcellular localizations of each aggregate [178]. Here, TARDBP is linked to amyotrophic lateral sclerosis.